World's Best Scientists 2026 revealed!
Clinical and Translational Science
H-index 31

Clinical and Translational Science

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 761 252 246 27

Additional Metrics

Number of Best Scientists*: 429
Documents by Best Scientists*: 354
Top 100 Ranked Scientists*: 7
SCIMAGO H-index: 65
SCIMAGO SJR: 1.219
Impact Factor: 2.8

Overview

Top Research Topics at Clinical and Translational Science?

The journal focuses on Internal medicine, Pharmacology, Pharmacokinetics, Translational research and Translational science. The Internal medicine works featured in Clinical and Translational Science incorporate elements from Gastroenterology, Endocrinology, Oncology and Cardiology. Pharmacology works presented in the journal have a specific focus on Drug.

While work presented in Clinical and Translational Science provided substantial information on Pharmacokinetics, it also covered topics in Placebo, Tolerability and Dosing. The study on Translational research presented in the journal intersects with the topics under Medical education. The studies tackled, which mainly focus on Medical education, apply to Curriculum as well.

The journal dives deep in exploring the relationship between the study of Translational science and Public relations.

  • Internal medicine (22.61%)
  • Pharmacology (13.77%)
  • Pharmacokinetics (13.48%)

What are the most cited papers published in the journal?

  • Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans (302 citations)
  • Recommendations for Planning Pilot Studies in Clinical and Translational Research (253 citations)
  • Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes (241 citations)

Research areas of the most cited articles at Clinical and Translational Science:

The published articles focus on Internal medicine, Medical education, Immunology, Translational research and Translational science. The published papers facilitate discussions on Internal medicine that incorporate concepts from other fields like Gastroenterology, Placebo and Endocrinology. The works on Translational research tackled in the published articles bring together disciplines like Research design, Gerontology, Community-based participatory research and Bioinformatics.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Cancer

The previous edition focused in particular on these issues:

The aim of the journal is to expand the discussion of research in Internal medicine, Pharmacokinetics, Pharmacology, Adverse effect and Pharmacodynamics. Clinical trial is a primary topic of Internal medicine research in the journal. It explores topics in Clinical trial which can be helpful for research in disciplines like Clinical pharmacology, Drug development and MEDLINE.

The overlapping concepts between Placebo and Anesthesia are the key highlights of Pharmacokinetics study. Pharmacology studies presented in the journal focus on topics such as Physiologically based pharmacokinetic modelling, Drug and Bioavailability. Most of the Adverse effect studies addressed also intersect with Discontinuation.

The most cited articles from the last journal are:

  • COVID-19 and immunological dysregulation: can autoantibodies be useful? (32 citations)
  • Risk Assessment of Drug-Induced Long QT Syndrome for Some COVID-19 Repurposed Drugs (15 citations)
  • Evolving Role for Pharmacotherapy in NAFLD/NASH. (14 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical and Translational Science (based on the number of publications) are:

  • Arthur M. Feldman (26 papers) absent at the last edition,
  • Andre Terzic (21 papers) absent at the last edition,
  • Scott A. Waldman (18 papers) absent at the last edition,
  • Arthur M. Feldman (14 papers) absent at the last edition,
  • Elaine Musgrave (14 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical and Translational Science (based on the number of publications) are:

  • Thomas Jefferson University (66 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • Mayo Clinic (66 papers) published 4 papers at the last edition, 1 more than at the previous edition,
  • University of Pittsburgh (61 papers) published 6 papers at the last edition,
  • National Institutes of Health (54 papers) published 7 papers at the last edition, 5 more than at the previous edition,
  • University of Washington (52 papers) published 9 papers at the last edition the same number as at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.64% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 19.93% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.54% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.73% of all publications and 54.80% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Careers in Clinical and Translational Science

The exciting field of Clinical and Translational Science offers a wide range of careers to individuals who have the passion for research and the desire to make impactful contributions to medicine and healthcare. The integration of different medical and scientific disciplines allows for a diverse range of career opportunities. Some individuals may choose to work as clinicians, applying their skills and knowledge to patient care in various medical specialists such as Internal Medicine, Pharmacology, and Oncology.

Others may pursue research-based roles, focusing on the development of new drugs and treatments through Pharmacokinetics and Translational Research. There are also roles that bridge the gap between research and public reception, such as in Public Relations, focusing on communicating scientific findings and their implications for the public.

In addition to traditional academic paths, a degree in Clinical and Translational Science can also lead to niche careers such as clinical trial coordinators or medical writers. Schools offering specialized tracks or programs in these areas provide a focused curriculum and unique opportunities for students.

For example, students in Delaware might consider programs like the Licensed Practical Nursing (LPN) programs that focus on preparing students for a practical role in healthcare. You can find more about the top lpn programs in Delaware to see if this path might suit your career goals.

Ultimately, no matter the specific path chosen, all careers in Clinical and Translational Science share a common goal: to improve health outcomes and advance the field of medicine.

Top Publications

  • Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.

    Kelly E. Caudle;Katrin Sangkuhl;Michelle Whirl‐Carrillo;Jesse J. Swen

    (2020)
    477 Citations
  • Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo‐controlled, double‐blind phase I/Ib studies in healthy subjects and patients

    (2022)
    70 Citations
  • The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence

    (2022)
    67 Citations
  • Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India.

    Alan H. Jobe;Mark A. Milad;Thomas Peppard;William J. Jusko

    (2020)
    57 Citations
  • Pharmacogenomics in Asian Subpopulations and Impacts on Commonly Prescribed Medications.

    Cody Lo;Samantha Nguyen;Christine Yang;Lana Witt

    (2020)
    56 Citations
  • Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice

    Mariamena Arbitrio;Francesca Scionti;Maria Teresa Di Martino;Daniele Caracciolo

    (2021)
    49 Citations
  • Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity

    Rachel Dalton;Seung-Been Lee;Katrina G Claw;Bhagwat Prasad

    (2020)
    47 Citations
  • Progress toward a universal biomedical data translator

    (2022)
    43 Citations
  • A Strategy to Treat COVID-19 Disease With Targeted Delivery of Inhalable Liposomal Hydroxychloroquine: A Preclinical Pharmacokinetic Study.

    Tien-Tzu Tai;Tzung-Ju Wu;Huey-Dong Wu;Yi-Chen Tsai

    (2021)
    40 Citations
  • Translating Minimally Invasive Glaucoma Surgery Devices.

    Richard M.H. Lee;Richard M.H. Lee;Yann Bouremel;Ian Eames;Steve Brocchini;Steve Brocchini

    (2020)
    39 Citations

Related Online Degrees & Career Pathways

For those interested in medicine but looking for alternative or complementary career options, several related online degree programs offer flexible learning paths. For example, a 2 year nutrition degree online provides a quick route into the health and wellness industry, focusing on diet and preventative care.

Healthcare professionals seeking leadership roles can consider pursuing a cheap online MBA healthcare administration. This degree equips students with management skills specifically tailored to healthcare settings, blending business acumen with medical knowledge.

For non-nurses aspiring to enter nursing rapidly, accelerated programs offer a streamlined path. The accelerated nursing programs for non nurses help candidates transition efficiently into registered nursing careers, often in less than two years.

Specialized nursing roles like psychiatric nurse practitioners are becoming increasingly vital. Understanding the earning potential is important, so exploring the psychiatric nurse practitioner salary by state can help prospective students and professionals make informed career decisions.

Best Scientists Contributing to This Journal